Clinical Trial: Enablers and Barriers to Hydroxyurea Use for Sickle Cell Disease Jamaica
Study Status: Completed
Recruit Status: RECRUITING
Condition: Sickle Cell Disease
Study Type: OBSERVATIONAL
Official Title: Access to Care for SCD Management in Jamaica: Enablers and Barriers to Hydroxyurea Utilization
Brief Summary:
Sickle cell disease (SCD) is associated with a lifetime of medical and socio-behavioural complications that require coordination of care from multidisciplinary teams.Access to adequate care for SCD is important as inadequate access can contribute to increased acute care utilization, disjointed care delivery, and earlier mortality for many SCD patients.Hydroxyurea (HU) is the first drug approved for the treatment of SCD and improves many adverse outcomes of SCD and yet its use remains sub-optimal.This mixed-methods…
Read more